Informations sur le produit
- 3-[(6-Deoxy-2-O-β-D-xylopyranosyl-α-L-mannopyranosyl)oxy]-7-(β-D-glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-bute n-1-yl)-4H-1-benzopyran-4-one
- 3-((6-Deoxy-2-O-beta-D-xylopyranosyl-alpha-L-mannopyranosyl)oxy)-7-(beta-D-glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one
- 3-[(6-Deoxy-2-O-β-<span class="text-smallcaps">D</smallcap>-xylopyranosyl-α-<smallcap>L</smallcap>-mannopyranosyl)oxy]-7-(β-<smallcap>D</span>-glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-4H-1-benzopyran-4-one
- 3-[(6-deoxy-2-O-beta-D-xylopyranosyl-alpha-L-mannopyranosyl)oxy]-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-4-oxo-4H-chromen-7-yl beta-D-glucopyranoside
- 4H-1-Benzopyran-4-one, 3-[(6-deoxy-2-O-β-<span class="text-smallcaps">D</smallcap>-xylopyranosyl-α-<smallcap>L</smallcap>-mannopyranosyl)oxy]-7-(β-<smallcap>D</span>-glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-
- 4H-1-Benzopyran-4-one, 3-[(6-deoxy-2-O-β-<span class="text-smallcaps">D</smallcap>-xylopyranosyl-α-<smallcap>L</smallcap>-mannopyranosyl)oxy]-7-(β-<smallcap>D</span>-glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-
- 4H-1-Benzopyran-4-one,3-[(6-deoxy-2-O-β-D-xylopyranosyl-α-L-mannopyranosyl)oxy]-7-(β-D-glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-
- Epimedin B(Primary Standard)
- 4H-1-Benzopyran-4-one, 3-[(6-deoxy-2-O-β-D-xylopyranosyl-α-L-mannopyranosyl)oxy]-7-(β-D-glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-
- 3-[(6-Deoxy-2-O-β-D-xylopyranosyl-α-L-mannopyranosyl)oxy]-7-(β-D-glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-4H-1-benzopyran-4-one
- Voir d'autres synonymes
Epimedin B is a natural product that has been shown to have antitumor activity. Epimedin B contains a variety of chemical structures that are thought to act on the cell surface and inhibit receptor binding, leading to the inhibition of tumor growth and progression. Epimedin B has been shown to bind to the response element in cervical cancer cells, which leads to an increased expression of transforming growth factor beta-1 (TGF-β1). Epimedin B also exhibits molecular docking with flavonoid glycosides, which may account for its antioxidant properties. The most active component in Epimedin B is phenolic acid. This compound is thought to be responsible for the anti-inflammatory and immunosuppressive activities observed in animal studies. In addition, phenolic acid is a potent inhibitor of nitric oxide synthase (NOS), an enzyme associated with tumor promotion.
Propriétés chimiques
Question d’ordre technique sur : 3D-OE08121 Epimedin B
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages